Skip to Content Facebook Feature Image

Altair and Cranfield University Sign MoU to Advance Use of Simulation, Data Analytics, and AI

Business

Altair and Cranfield University Sign MoU to Advance Use of Simulation, Data Analytics, and AI
Business

Business

Altair and Cranfield University Sign MoU to Advance Use of Simulation, Data Analytics, and AI

2025-01-28 20:00 Last Updated At:20:15

Altair solutions help students and startups pioneer next-generation advancements in aerospace and robotics

TROY, Mich., Jan. 28, 2025 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational intelligence, and U.K.-based Cranfield University have signed a memorandum of understanding (MoU) to explore and expand the use of artificial intelligence (AI), simulation, and data analytics within the aerospace and robotics industries. The organizations will also support students, researchers, and startups looking to harness the power of computational intelligence within these industries.

"Cranfield University is a proven leader and innovator in aerospace and beyond," said Pietro Cervellera, senior vice president of aerospace and defense, Altair. "This MoU is just the first step in developing new breakthroughs and helping organizations of all kinds explore the immense power of simulation, data analytics, and AI within aerospace."

"We're looking forward to working together with Altair to identify ways we can integrate technologies to support students and their research projects, and accelerate startups already working with Cranfield," said professor Antonios Tsourdos, director of AI, robotics, and space, Cranfield University. "We anticipate great things from our joint efforts and are delighted to work with Altair experts to drive next-generation aerospace innovation."

The agreement comes at a time when the convergence of AI, machine learning, data analytics, and simulation is increasingly pivotal in developing new innovations in areas like autonomous space exploration, Earth observation, telecommunications, and defense.

Cranfield University is a leading global university and has world-renowned expertise in aerospace research and innovation. It is the only university in Europe with its own airport and runway and is the U.K.'s largest provider of accredited aerospace and space master's degree courses.

To learn more about Altair's aerospace capabilities, visit https://altair.com/altair-rapidminer. To learn more about Cranfield University, visit https://www.cranfield.ac.uk/.

About Cranfield University
Cranfield is a specialist postgraduate university with globally renowned expertise in science, technology, engineering and management. We deliver applied research that has real-world impact – 88% of our research is world-leading or internationally excellent (REF2021). For more information, visit www.cranfield.ac.uk.

About Altair
Altair is a global leader in computational intelligence that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI. Altair enables organizations across all industries to compete more effectively and drive smarter decisions in an increasingly connected world – all while creating a greener, more sustainable future. To learn more, please visit www.altair.com.

Media contacts

Altair Corporate                                             

Altair Investor Relations

Bridget Hagan                                                 

Stephen Palmtag

+1.216.769.2658                                           

+1.669.328.9111

corp-newsroom@altair.com                   

ir@altair.com

Altair Europe/The Middle East/Africa   

Altair Asia-Pacific

Louise Wilce                                                     

Man Wang

+44 (0)7392 437 635

86-21-5016635,,825

emea-newsroom@altair.com                   

apac-newsroom@altair.com

Cranfield University

Kath Middleditch

+44 (0) 1234 754 594

kath.middleditch@cranfield.ac.uk

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Altair and Cranfield University Sign MoU to Advance Use of Simulation, Data Analytics, and AI

Altair and Cranfield University Sign MoU to Advance Use of Simulation, Data Analytics, and AI

JOHNSON CITY, Tenn., Feb. 4, 2025 /PRNewswire/ -- LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its Strategic Advisory Board and the appointment of its inaugural members. This board will further cement LabConnect's position as a global leader in the industry, supporting its ongoing international expansion and significant investments in innovation and technology. The Strategic Advisory Board has been specifically designed to accelerate LabConnect's goal of delivering more efficient, transparent, sustainable, and insightful solutions for its clients and partners.

The distinguished members of the Strategic Advisory Board include:

Scott Evangelista
Mr. Evangelista brings over 30 years of pharmaceutical leadership experience to the board. He is currently the CEO of Cairn Therapeutics, Inc., where he directs the company's strategy, fundraising, and stakeholder management. Previously, Scott served as Executive Chairman at Cairn and has held prominent roles such as President and COO of Ironshore Pharmaceuticals, President of Integrated Health Services at IQVIA (formerly Quintiles), and Principal of the Life Sciences Commercial practice at Deloitte Consulting. Additionally, he sits on the Board of Worldwide Clinical Trials. Scott's extensive background in pharmaceutical leadership and strategic management will be instrumental in driving LabConnect's growth and innovation.

David Johnston, Ph.D.
Dr. Johnston joins the board with a robust background in scientific and operational leadership. As the Senior Vice President and President of Clinical Research at Thermo Fisher, following the acquisition of PPD, David has led global clinical development and laboratory services at PPD and LabCorp, as well as scientific advisory roles at numerous bioscience CROs. His deep knowledge in clinical development operations and patient recruitment will enhance LabConnect's efforts to boost productivity and reduce clinical development costs.

Patrick Hastings
Mr. Hastings is a highly accomplished operations and business development executive with a proven track record in the pharmaceutical and clinical laboratory sectors. Formerly the Global VP at Labcorp, Patrick led the Central Laboratory Services business unit. His leadership experience spans roles at Eli Lilly, Mossberg Labs, Bayer Healthcare, and Merck & Co. Patrick's expertise in lab and pharmaceutical operations, manufacturing, and supply chain will be pivotal in driving LabConnect's operational excellence and business performance.

"We are delighted to welcome Scott, David, and Patrick to our Strategic Advisory Board," said Wes Wheeler, CEO of LabConnect. "Their combined expertise and leadership will be crucial in advising LabConnect as we continue to innovate and expand our global footprint. This board will play a vital role in helping us deliver exceptional value to our clients and partners."

LabConnect remains committed to creating healthier communities by supporting our clients in successfully developing new medicines for patients around the world. The formation of the Strategic Advisory Board marks a significant milestone in LabConnect's ongoing journey to solidify its position as a global leader in the industry.

About LabConnect
LabConnect is the leading provider of Central Laboratory Services, FSP and Scientific Consulting, and Data Integration and Transformation Services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare & orphan diseases. LabConnect's unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs. Learn more at www.labconnect.com and follow on LinkedIn.

Logo - https://mma.prnasia.com/media2/2611513/LabConnect_Logo.jpg?p=medium600

Photo - https://mma.prnasia.com/media2/2611514/LabConnect_US_Headquarters.jpg?p=medium600

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

LabConnect Announces Formation of Strategic Advisory Board and Appointment of Inaugural Members

LabConnect Announces Formation of Strategic Advisory Board and Appointment of Inaugural Members

Recommended Articles
Hot · Posts